AHG is the ticker symbol for Akso Health Group, a publicly traded Industrials sector company listed on Nasdaq. 13F Pro tracks AHG with AI-powered analysis, a 32-signal quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is AHG a good stock to buy?

AHG is tracked on 13F Pro with SEC EDGAR data, but is not currently included in our 32-signal AI quality ranking. The full company profile with financials and AI insights is at https://13fpro.ai/company/AHG.

Where does 13F Pro source AHG data?

All Akso Health Group fundamentals and ownership data come directly from SEC EDGAR. Akso Health Group files with the SEC under CIK 1702318. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

Akso Health Group(AHG)— Stock Profile, AI Score & Financials

Industrials · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-03-31.

Akso Health Group (AHG) stock profile, AI quality score, and SEC EDGAR financial data, a Industrials sector company. AHG is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 11 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2026), Akso Health Group reports quarterly revenue of $13.8M, net income of $-18.7M, free cash flow of $-12.8M. Top institutional holders of AHG by reported 13-F value include RENAISSANCE TECHNOLOGIES, NORTHERN, CITADEL ADVISORS, based on the most recent SEC filings. AHG trades on the Nasdaq exchange and files with the SEC under CIK 1702318. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AHG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Akso Health Group directly from SEC EDGAR.

Revenue

$13.8M

Net Income

$-18.7M

Free Cash Flow

$-12.8M

AHG key financials by period

Akso Health Group reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Operating margin
FY 2026	20-F	$13.8M	$-18.7M	-149.7%
FY 2025	20-F	$14.8M	$-135.0M	—
FY 2024	20-F	$2.4M	$-9.5M	—
FY 2023	20-F	$13.2M	$-1.4M	-108.2%
FY 2022	20-F	$6.0M	$-16.9M	-54.3%
FY 2021	20-F	$1.8M	$-34.8M	—

Institutions holding AHG

Institutional investors reporting a position in Akso Health Group on SEC Form 13F.
Institution	Shares	Value	Reported
RENAISSANCE TECHNOLOGIES	70,943	$105.7K	2026-06-30
NORTHERN	51,403	$76.6K	2026-06-30
CITADEL ADVISORS	46,026	$68.6K	2026-06-30
SmartHarvest Portfolios	44,755	$66.7K	2026-06-30
JANE STREET GROUP	41,360	$61.6K	2026-06-30
GEODE CAPITAL MANAGEMENT	14,973	$22.3K	2026-06-30
BlackRock	10,064	$15.0K	2026-06-30
UBS Group AG	963	$1.4K	2026-06-30
MORGAN STANLEY	739	$1.1K	2026-06-30
HUNTINGTON NATIONAL BANK	419	$624.00	2026-06-30

SEC EDGAR: CIK 1702318 →

Akso Health Group

AHG

NasdaqMid CapIndustrials

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 11 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.